Phase II failures: 2008–2010
- Authors
- John Arrowsmith
- Journal
- Nature Reviews Drug Discovery
In The Last Decade
doi.org/10.1038/nrd3439 →Countries where authors are citing Phase II failures: 2008–2010
This map shows the geographic impact of Phase II failures: 2008–2010. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phase II failures: 2008–2010 with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phase II failures: 2008–2010 more than expected).
Fields of papers citing Phase II failures: 2008–2010
This network shows the impact of Phase II failures: 2008–2010. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Phase II failures: 2008–2010.
About Phase II failures: 2008–2010
This paper, published in 2011, received 429 indexed citations . Written by John Arrowsmith. It is primarily cited by scholars working on Molecular Biology (164 citations), Computational Theory and Mathematics (119 citations) and Oncology (66 citations). Published in Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nrd3439.